Orgenesis inks Koligo buyout to gain COVID-19 cell therapy

cafead

Administrator
Staff member
  • cafead   Sep 29, 2020 at 12:02: PM
via Orgenesis has struck a deal to acquire Koligo Therapeutics. The takeover will give Orgenesis control of an autologous cell therapy treatment for respiratory disease caused by COVID-19.

article source